Profil Institute's Dr. Marcus Hompesch Named Finalist in Ernst & Young Entrepreneur Of The Year(R) 2010 Award for Second Year in a Row

SAN DIEGO, May 12 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc. (PICR) today announced that president and CEO Dr. Marcus Hompesch is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in San Diego for the second year in a row. Award winners will be announced at a gala event on June 9, 2010 at the Hyatt La Jolla Aventine.

Dr. Hompesch is being recognized for his establishment and leadership of PICR, headquartered in Chula Vista, Calif.  PICR has emerged as an industry leader in performing phase I and II clinical trials for pharmaceutical companies by honing their clinical expertise and specifically focusing on new treatments for diabetes and obesity.  

Under Dr. Hompesch's leadership, the team at PICR has conducted more than 120 clinical studies investigating new drugs and devices since the company began operations in 2004 and has been involved with almost every clinically promising drug and device development in the diabetes arena.

"I am honored to have been selected as a finalist for this prestigious award for a second year in a row," said Dr. Hompesch. "It is not only personally rewarding to be recognized with these highly respected entrepreneurs, but is, in fact, a wonderful testament to what our team at PICR has been able to accomplish."

Dr. Hompesch is one of three finalists in the Health Sciences category for the San Diego regional awards ceremony. The other finalists in this category are Jonathan Lim, President and CEO of Halozyme Therapeutics, and Scott Huennekens, President and CEO of Volcano Corporation. Past years' winners include Alex V. Lukianov of NuVasive, Inc. in 2009, Jay Flatley of Illumnia, Inc. in 2008 and Tina Nova of Genoptix, Inc. in 2007.

Now entering its 24th year, the Ernst & Young Entrepreneur of The Year awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities.

Regional award winners will be eligible for consideration in the Ernst & Young Entrepreneur of The Year national program. Winners in a number of national categories, as well as the overall national Ernst & Young Entrepreneur of The Year award winner, will be announced at the annual awards gala in Palm Springs, California in November.

About Profil™ Institute for Clinical Research, Inc.

PICR is a privately held institute providing high quality early phase clinical research services in diabetes and obesity. PICR uses its expertise to guide the developmental planning, design and actual performance of early phase clinical studies that help in the determination of whether a new compound should be carried forward into the later phases of clinical development. In order to make reliable and solid development decisions based on the most accurate data, PICR utilizes specific research methods, including the automated glucose clamp procedure, which is accepted as the gold standard for pharmacodynamic data. The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Dusseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit www.profil-research.com

For more information on Ernst & Young's Entrepreneur Of The Year® awards program, please visit www.ey.com/us/eoy. 

SOURCE Profil Institute for Clinical Research, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED